Neural Plasticity

Neural Plasticity / 2021 / Article
Special Issue

Reestablishing Neural Plasticity in Regenerated Spiral Ganglion Neurons and Sensory Hair Cells for Hearing Loss 2021

View this Special Issue

Review Article | Open Access

Volume 2021 |Article ID 4784385 | https://doi.org/10.1155/2021/4784385

Huanyu Mao, Yan Chen, "Noise-Induced Hearing Loss: Updates on Molecular Targets and Potential Interventions", Neural Plasticity, vol. 2021, Article ID 4784385, 16 pages, 2021. https://doi.org/10.1155/2021/4784385

Noise-Induced Hearing Loss: Updates on Molecular Targets and Potential Interventions

Academic Editor: Hai Huang
Received08 Apr 2021
Accepted12 Jun 2021
Published07 Jul 2021

Abstract

Noise overexposure leads to hair cell loss, synaptic ribbon reduction, and auditory nerve deterioration, resulting in transient or permanent hearing loss depending on the exposure severity. Oxidative stress, inflammation, calcium overload, glutamate excitotoxicity, and energy metabolism disturbance are the main contributors to noise-induced hearing loss (NIHL) up to now. Gene variations are also identified as NIHL related. Glucocorticoid is the only approved medication for NIHL treatment. New pharmaceuticals targeting oxidative stress, inflammation, or noise-induced neuropathy are emerging, highlighted by the nanoparticle-based drug delivery system. Given the complexity of the pathogenesis behind NIHL, deeper and more comprehensive studies still need to be fulfilled.

1. Introduction

Hair cells (HCs) in the inner ear cochlea function in transducing sound waves into electric signals [14], while supporting cells function in supporting the HCs and providing the potential pool for HC regeneration [59]. Damages from a variety of sources can impair HC function, including mutations in deafness genes, aging, ototoxic drugs, chronic cochlear infections, and noise exposure [1013]. Acoustic overexposure would result in sensorineural hearing loss characterized by high-frequency hearing threshold shift mainly, termed as noise-induced hearing loss (NIHL)[14], which is due to loss or damage of sensory HCs and degeneration of the spiral ganglion neurons (SGNs). Though noise susceptibility is quite individual, it is normally acknowledged that noise above 85 dB would be considered as hearing harmful [15, 16]. Studies [1719] have shown that mild or moderate noise would only trigger temporary hearing threshold shift (TTS), because the noise-induced hair cell damage and auditory nerve fiber degeneration were still reversible. Hearing ability is commonly measured by auditory brainstem response (ABR) and distortion product otoacoustic emission (DPOAE) test [20]. The ABR threshold and DPOAE level would recover to prenoise level over time in TTS patients. However, severe noise exposure, referring as strong sound vibrations, or longtime exposure to harmful noise, or both, can lead to cochlear hair cell necrosis and apoptosis, causing permanent threshold shift (PTS)[16, 21]. Although the neonatal mammals still have very limited HC regeneration ability, the adults have lost this ability [2226], leading to the irreversible loss of HCs after noise damage. Besides decrease of auditory sensitivity and language recognition ability, NIHL patients could suffer from headache, tinnitus, dizziness, hypertension, etc. [14, 17].

It is estimated that about 5% of the world’s population suffer from disabling hearing loss [27]. Modern people are exposed to acoustic trauma with increasingly higher risk as the industrialization of society. Strikingly, evidence has shown that acoustic trauma-induced hearing impairment aggravates microglial deterioration around the hippocampus, indicating its potential causal role in the pathogenesis of dementia, which exacerbates the already overloading public health burden of NIHL [28]. Therefore, more and more attention has been focused on revealing the pathogenesis mechanisms and effective therapeutics of NIHL. We review the updates on molecular targets about NIHL, summarize the approved and potential medications for NIHL treatment, and propose the controversies and foreseeing on NIHL.

2. Cellular Pathologies

Acoustic shock with strong sonic energy caused temporary or permanent cellular pathologies. Hair cells, especially outer hair cells (OHCs), are the main targets of noise trauma. Noise overexposure causes hair cells swelling and eventual irreversible death [29]. Noise-induced sensory hair cell impairment also accompanies by collapse and loss of stereocilia and destruction of their tip connection. Interestingly, the loss of tip links connecting adjacent stereocilia would increase noise susceptibility reversely [3032]. Acoustic overstimulation can also cause the reduction of synaptic connections between hair cells and spiral ganglion cells, afferent fiber swelling, and auditory nerve deterioration [3337].

It is widely recognized that noise with is hearing harmful, while extremely high intensity noise like blast or gunshot could do much more harm to the hearing system within very short exposing time. The latter has been given a special name termed blast-induced hearing loss to highlight its difference from chronic NIHL [38]. Besides the damage of hair cells and spiral ganglion neurons, high intensity noise can result in middle ear damage like tympanic membrane perforation, ossicular chain dislocation, oval/round window rupture, and thus external lymph fistula [39]. The stria vascularis and spiral ligament are also attacked by intense noise, resulting in lower blood flow and lower vessel diameter in the stria vascularis [40]. Hearing impairment is the foremost clinical symptom of blast overexposure injury. Besides that, blast may also cause otitis media because of the rupture of tympanic membrane and secondary infection [41]. Vertigo and balance disorder occur in patients accompanied by labyrinthine damage and hemorrhage after blast exposure, which leaves headache and dizziness for a long time after the accident. Therefore, the treatment of blast-induced hearing loss often involves operations like tympanoplasty to repair tympanic membrane and rebuild ossicular chain [42].

3. Molecular Pathogenesis

Acoustic trauma features hair cell loss, synaptic ribbon deterioration, and acoustic nerve degeneration. Previous studies [43, 44] have proved that after noise exposure, both necrosis and apoptosis occurred in the sensory epithelium. However, the causative mechanisms inducing necrosis and apoptosis are much complex and intertwined (Figure 1).

3.1. Oxidative Stress

Though the exact mechanism behind NIHL is not fully explained yet, various studies [4547] have suggested that oxidative stress in the cochlea contributes to the noise-induced hearing impairment. Ohlemiller et al. [45] have proved that the production of hydroxyl radical, a main kind of reactive oxygen species (ROS), increases over four times upon acoustic trauma in cochlear perilymph. ROS, mainly generated from the leaking electrons in the mitochondrial electron transport chain, is crucial for multiple physiological behaviors like cell proliferation and differentiation in relative low content [46, 48]. Under physiological circumstances, the production and scavenging of ROS are maintained at balance subtly and dynamically. Many stress stimulators like extensive sound exposure as well as ototoxic drugs like cisplatin [47] and aminoglycosides [4956] can increase ROS production in hair cells, which is beyond the maximal cellular antioxidative ability, and threaten the integrity of DNA, protein, and other survival-crucial macromolecules [57]. Similar to ROS, reactive nitrogen species (RNS) also contribute to the noise-induced cochlear oxidative imbalance [58]. Overproduction of ROS/RNS in hair cells and spiral ganglion neurons is well studied [59, 60], whereas the role of oxidative stress in supporting cells still needs further explanation. Styrene was applied to induce specifically oxidative damage in cochlear supporting cells, and hearing ability was also apparently impaired [61]. However, how oxidative stress in supporting cells participates in NIHL progression requires deeper exploration.

The production and scavenging of ROS/RNS are mediated by various endogenous antioxidants and antioxidative enzymes [57]. The enzymes producing ROS/RNS are usually kept at low expressing level in hypermetabolic cells like acoustic hair cells, tumor cells, and cardiac myocytes, which are oxidative stress sensitive. The NADPH oxidase family (NOX) has been proved to catalyze the electron transport from NADPH to oxygen molecules to speed up ROS production [62]. The NOX4 transgenic mice which constitutively expressed human NOX4 were found to be noise susceptible while they had normal hearing threshold without acoustic stimulation, stressing the vital role of imbalance of redox homeostasis in NIHL [63].

Besides ROS/RNS overproduction, the inducible transient upregulation of antioxidative genes also features the pathogenesis of NIHL as a physical feedback mechanism. Nrf2, which is widely expressed in multiple tissues such as the heart, liver, and cochlea, can respond to oxidative stress and activate downstream antioxidative gene expression like glutathione peroxidase (GPx), NAD(P)H:quinone oxidoreductase 1 (NQO1), heme oxygenase-1 (HO-1), and catalase (CAT) [6466]. Nrf2 signaling can also activate autophagy in hair cells via p62 protein for oxidative stress amelioration [67]. More and more researches [67, 68] have proved that targeting Nrf2 signaling is a promising therapeutic solution for NIHL.

Given the fact that oxidative stress is one of the key contributors to the pathogenesis of NIHL, it is reasonable to assume that genes involved in the redox homeostasis correlate to noise vulnerability of the cochlea [69]. Superoxide dismutase (SOD) and paraoxonases (PONs) are two antioxidative enzymes found in the cochlea; the former directly catalyzes superoxide radicals to less toxic hydrogen peroxide while the latter decreases lipid peroxidation activity [70]. It is reported that the polymorphisms of SOD2, PON1, and PON2 are related to susceptibility to NIHL in workers with high occupational noise trauma risk [69, 71]. Meanwhile, overexpression of SOD1 was found to provide a protective effect on noise-related hearing loss [72]. Another newly emerging medication named nicotinamide, the NAD+ precursor, can boost NAD+ content and ameliorate NIHL in a SIRT3-dependent way [73]. SIRT3 plays an important role in maintaining the function of various antioxidative enzymes while impaired SIRT3 resulted in ROS overproduction and decreased levels of GSH [74, 75].

3.2. Autophagy

Autophagy, as a recently found endogenous self-defense mechanism, degrades damaged organelles by lysosome to maintain internal homeostasis and preserve energy providing for cell survival upon stress like nutrient deficiency, pathogen infection, protein misfolding, and oxidative stress [7680]. Previous studies [81, 82] have shown that autophagy is upregulated in auditory hair cells after intense noise exposure. The immunostaining results show the upregulation of LC3b, the indispensable component of autophagosome, and the colocalization of LC3b and Lamp1, indicating the enhanced fusion of autophagosome and lysosome. To test the hypothesis of autophagy as the cochlear endogenous defenses against NIHL, researchers analyzed whether the disruption of autophagy could exacerbate NIHL with autophagy direct inhibitor 3-MA and mTOR signaling agonist RAP. mTOR protein is one of the main negative regulators for autophagy induction because it can phosphorylate Atg13 to cut off the beginning phase of autophagosome formation [83]. Notably, the inhibition of autophagy worsened the noise-induced oxidative imbalance and the eventual hair cell loss and impaired hearing ability [81].

Pejvakin protein is recently identified as the oxidative sensor in auditory hair cells. Researchers applied immunostaining colocalization analysis and in situ PLA technology to testify the enhanced interactions between pejvakin and LC3B, as well as pejvakin and PMP70 (the marker of peroxisome) in hair cells after acoustic trauma or simply H2O2 treatment. Furthermore, pejvakin is found to mediate peroxisome autophagy after noise exposure, which is vital to secondary peroxisome proliferation and oxidative homeostasis maintenance afterwards. Pejvakin-mutated mice show impaired peroxisome proliferation and more severe oxidative stress in auditory hair cells after noise exposure [84].

3.3. Inflammation

The cochlea was used to be considered as immune exemption organ because of the blood-perilymph barrier [85]. However back in 2008, Okano et al. [86] transplanted the EGFP-positive hematopoietic stem cells (HSCs) into wide-type C57BL/6 mice to label the bone marrow-derived cells (BMDCs) with green fluorescence and found EGFP-positive cells in cochlear spiral ganglion and spiral ligament regions of the HSC transplanted mice. Interestingly, EGFP-positive cells were colocalized with F4/80, Iba1, and CD68 immunostaining marks, indicating the presence of bone marrow-derived cochlear resident macrophage-like cells. Like microglia in the nervous system, supporting cells can also be stained with various macrophage markers surprisingly. LPS treatment can induce phagocytosis of supporting cells, which is the direct functional evidence linking cochlear supporting cells with macrophages [87]. Recently, more and more researches suggest the key role of inflammation in aging, drug, and noise-induced ototoxicity [10]. It is notable to point out that inflammation is a dual sword that requires a very complicated and delicate regulatory network involving multiple genes and transcription factors. After acoustic trauma, inflammatory cells representing CD45, CD68, and Iba1 positive infiltrate and proliferate in the cochlea, especially in the stria vascularis, with high expression of CX3CR1, the receptor of a classic chemokine [88, 89]. These inflammatory cells can synthesize and release a variety of proinflammatory cytokines like interleukin-1β (IL-1β), interleukin-6 (IL-6), and tumor necrosis factor-α (TNF-α)[90]. IL-1β and IL-6, the markers of acute inflammation belonging to the interleukin superfamily, contribute to the mononuclear phagocyte infiltration and subsequent release of elastase and prostaglandin, bringing to excessive inflammation cascade activation resulting in microcirculation disturbance, tissue destruction, and eventual hearing impairment [88, 89, 91].

Targeting TNF-α inhibition by molecules or siRNA also attenuates the noise-induced cochlear inflammation and thus hearing threshold shift [9294]. It is reported that noise-induced increase of TNF-α can be regulated by nuclear factor of activated T cells 4 (Nfatc4), a well-researched transcription factor served as proinflammatory cytokine inducer. Nfatc4 knockout mice show resistance to TNF-α-mediated hair cell apoptosis triggered by intense noise [95]. Notably, TNF-α is testified to be able to induce calcium influx through ERK-dependent activation of TRPV1. Desensitization of TRPV1 by capsaicin ameliorates TNF-α-induced calcium influx and hair cell apoptosis in NIHL modeling mice [96].

Tumor growth factor-β (TGF-β) has been proved to be pluri-regulatory in cochlear development and homeostasis maintenance such as otic capsule formation [97], spiral ganglion neuron survival [98, 99], and inflammation responses [100]. TGF-β initially serves as the inducer of adhesion and chemoattractive molecules for the chemotaxis and activation of leukocytes, and downregulates the interleukin production reversely as the inflammation progresses, indicating its double effects on inflammation regulation [101103]. Reportedly, the mRNA expression level of TGF-β is upregulated in the cochleae upon noise trauma. Using P7 and P144, two peptides targeting TGF-β inhibition, significantly improves hearing compared to the control group in NIHL mouse model [104]. Further evidence indicates that TGF-β inhibitor decreased the NOX4 content, which is proved to promote NLRP3 inflammasome activation by oxidating fatty acids [105].

It is well testified that nuclear factor kappa B (NF-κB) and its target proinflammatory genes play the central roles in inflammation regulation. Previous researches [94, 106, 107] have found that NF-κB signaling cascade can be activated by noise trauma and inhibition of NF-κB can decrease the content of proinflammatory cytokines. Glucocorticoid is the most commonly used medication for the treatment of NIHL, and its pharmaceutical activity is reported to be partly mediated by NF-κB inhibition [108]. Another interesting discovery about NIHL is that mice show greater sensitivity to noise overexposure during the night [109]. The circadian sensitivity alteration of the cochlea is proved to be adrenal gland-derived endogenous glucocorticoid dependent for its key role on inflammation regulation [110]. Besides, proinflammatory meditators like cyclooxygenase-2 (COX2) and NADPH oxidase 3 (NOX3) are also found upregulated after noise exposure, verifying the indispensable role of inflammation in the pathogenesis of NIHL [94].

3.4. Glutamate Excitotoxicity and Neuropathy

The acute cochlear synaptic ribbon disruption and lasting acoustic neural degeneration also underlie the NIHL pathogenesis. Studies [111, 112] have proved that glutamate excessive accumulation serves as the contributor to acute and chronic deterioration of the auditory nervous system. Glutamate is subtly regulated and remains at a very low level in the synaptic cleft. The overloading of glutamate might dysregulate the cystine-glutamate transporter and result in cystine and thus GSH deficiency, or constantly activate the glutamate receptor in the postsynaptic membrane and damage the afferent neural fibers [113, 114]. GLAST, one of the five classic glutamate transporters, is found to be expressed in supporting cells located around the inner hair cells. GLAST plays a crucial role in glutamate uptake for its rapid recirculation in the synaptic cleft between the inner hair cells and afferent auditory neural fibers, and depletion of GLAST leads to excessive accumulation of glutamate, which might trigger calcium overload in spiral ganglion neurons. The knockout of GLAST exacerbates the hearing loss in transgenic mice, indicating the potential role of glutamate excitotoxicity in NIHL [111]. The release of glutamate from inner hair cells is also vesicular glutamate transporter type-3 (vGlut3) dependent. Despite the fact that glutamate excitotoxicity relates to NIHL pathogenesis, glutamate also has its dual effects on the noise-induced synapses loss. vGlut3-KO mice show moderate to severe hearing loss due to the impaired synaptic connection development for IHCs and acoustic nerve fibers. And Vglut3+/- mice show disrupted synaptic ribbon recovery after acoustic trauma, indicating that glutamate also participates in the repair of ribbon synapses in TTS model of NIHL [112].

Previous studies [115, 116] have suggested that calcium overload as a vital contributor to glutamate excitotoxicity. There are two main kinds of glutamate receptors in the postsynaptic region, termed as N-methyl-d-aspartate (NMDA) receptor and α-amino-3-hydroxy-5-methyl-4-isoxazole-propionate (AMPA) receptor [117]. Though NMDA receptors play the key role in calcium influx and consequent excitotoxicity in the central nervous system, intratympanic injection of NMDA receptor antagonist AM-101 shows no obvious protective effect on the tone ABR threshold at any frequencies, indicating that calcium influx mediated by NMDA receptors is not the most important contributor of glutamate excitotoxicity in the cochlea [115].

As for AMPA receptor, it is an ionic channel type receptor of glutamate, containing four subunits, namely, GluA1, GluA2, GluA3, and GluA4. Once activated, AMPA receptors mediate fast moving of multiple ions crossing cellular membrane [117, 118]. GluA2 has been testified to decrease Ca2+ permeability greatly [119121]. Recent studies have revealed the existence of GluA2-lacking calcium-permeable AMPA receptors (CP-AMPARs) [116, 122]. Interestingly, IEM-1460, a CP-AMPAR inhibitor, significantly ameliorates the noise-induced decline of synapse integrity, as well as ABR threshold shift, shedding light on the therapeutic potential of NIHL by targeting CP-AMPARs [116].

The reduction of synaptic ribbons and acoustic neural degeneration is reversible in noise-induced transient hearing loss. It is reported that the recovery of cochlear synaptic ribbons after noise exposure is regulated by some endogenous neural factors named neurotrophins. Neurotrophins are endogenous molecules which are vital to the morphogenesis of nervous system development and neuron survival. Brain-derived neurotrophic factor (BDNF) and neurotrophin-3 (NT-3) are highly expressed in the inner hair cells and supporting cells to guide the auditory neural fibers to form precise synaptic connection in postnatal mice and stabilize the connection in adult mice [123]. Knockout of Ntf3 in supporting cells using Plp1-CreER mouse line impairs the high-frequency hearing while Bdnf depletion does not. Reversely, overexpression of Ntf3 or Bdnf in supporting cells and hair cells both attenuate the noise-induced synaptic ribbon reduction and eventual hearing loss [124]. Direct administration of NT-3 also attenuates NIHL progression [125]. Interestingly, as the detection technology develops into more microcosmic level, NT-3 is also found in the extracellular vesicles from human multipotent stromal cells (MSC-EVs). And administration of MSC-EVs not only raises the survival rate of spiral ganglion neurons cultured in vitro but also ameliorates the NIHL in vivo [126].

The effect of BDNF on NIHL is quite complicated and controversial. Many studies have reported that BDNF administration can enhance auditory neuron survival [127129]. Meanwhile, tropomyosin-related kinase type B (TrkB, a selective BDNF receptor) agonist DHF [109], amitriptyline, and 7,8-dihydroxyflavone [130] increase resistance to acoustic trauma. However, genetically, depletion of Bdnf gene in adult mice shows protective effect against NIHL because of impaired glutamate release from IHCs, indicating the essential role of BDNF for maintenance of IHC function as well [131].

3.5. Calcium Overload

Calcium is one of the most important ions for the development and physiological function of the inner ear [132, 133]. Under physiological circumstances, calcium content in hair cells and spiral ganglion neurons is quite low [134, 135]. In response to the sound stimulation, calcium influx and calcium-induced calcium release (CICR) from the endoplasmic reticulum significantly increase intracellular calcium and trigger the release of neurotransmitter from the IHCs to transform mechanical signals to electrical signals [136, 137]. Moreover, the spontaneous calcium spike from the IHCs also participates in the formation and functional maturation of the afferent auditory nerve [138]. Calcium takes part in various physiological functions as one of the main second messenger molecules, while excessive accumulation of calcium under stress like ischemia-reperfusion injury [139] contributes to cell death in several pathways. Previous studies show that calcium is also involved in the acoustic ototoxicity [135, 140, 141]. Intracellular calcium concentration is significantly upregulated in auditory hair cells, especially outer hair cells shortly after acoustic overstimulation though returns to basal level within 30-45 minutes [135]. The calcium concentration is also found increased abruptly in endolymph of the cochlea after intense noise exposure [141]. Minami et al. have reported that the expression of calcineurin, a calcium/calmodulin-dependent phosphatase, is restrictedly increased in dying hair cells marked by propidium iodide after noise overstimulation [142]. Calcineurin can dephosphorylate and activate the classic proapoptotic protein BAD, and the systemic administration of calcineurin inhibitor FK506 reduced the apoptosis of hair cells evidently [142, 143].

Though strong evidence has proved that excessive calcium overload contributes to noise-induced hair cell death, the pharmacological drug development targeting calcium overload is still contentious. Voltage-gated calcium channels (VGCCs) facilitating calcium influx are proved to be responsible for the noise-induced intracellular calcium overload. There are five different types of VGCCs, namely, L-, T-, N-, P/Q-, and R-type [144]. It is reported that administration of T-type calcium channel blockers like ethosuximide and trimethadione prior to noise exposure can effectively reduce the hearing threshold shift [145]. However, other researchers suggest that L-type calcium channel blockers [146] attenuate NIHL while T-type calcium channel blockers cannot.

3.6. Energy Metabolism

Transient ATP depletion in the cochlear perilymph following acoustic trauma has been proved by studies [147, 148]. Likewise, the extracellular ATP content in the inner ear also decreased upon ischemia stress [149]. Since either the production of endogenous antioxidants or the recovery of spiral ganglion cells upon noise exposure is energy consuming, researchers proposed the hypothesis that transient ATP depletion might weaken the defense ability of the cochlea against acoustic trauma. 5-Adenosine monophosphate- (AMP-) activated protein kinase (AMPK), the energy sensor protein responding to fluctuation of intracellular AMP/ATP ration [150], has been reported to be activated by noise-induced ATP depletion and responsible for the pathogenesis of NIHL [44]. Parallel to transient energy exhaustion, AMPK activates Rac-1, belonging to GTPase family which can phosphate its downstream targets via hydrolyzing GTP and trigger p67 protein phosphorylation [151]. p67 is one of the functional subunits of NADPH oxidase 3 (NOX3), which contributes to noise overexposure-induced ROS overproduction in hair cells and eventual cell death [152]. Reversely, excessive ROS accumulation also activates the AMPKα signaling, marked by enhanced phosphorylated AMPKα, while systematical administration of antioxidant N-acetyl-L-cysteine (NAC) decreases both phosphorylated AMPKα and oxidative stress [153]. Noise-induced phosphorylation of AMPKα is also regulated by liver kinase B1 (LKB1), mediated by the transient intracellular ATP depletion. Indirect inhibition of AMPKα or its upstream regulatory gene LKB1 can ameliorate noise-induced necrosis of acoustic hair cells [147].

However, there is hardly any effective way to boost energy generation in hair cells after noise exposure. It is reported that transient increasing serum glucose level with administration of glucose can strengthen the cochlear defense system against NIHL by increasing ATP and NADPH content in hair cells [154]. Nevertheless, the diabetic mice with constant high blood glucose show much more severe noise-induced hair cell death and spiral ganglion neuron loss, which might be due to the blood flow ration reduction induced by chronic inflammation [155].

3.7. Others
3.7.1. Matrix Metalloproteinases

Matrix metalloproteinases (MMPs) play a key role in the extracellular matrix (ECM) homeostasis and remodeling. For example, MMP-2 is reported to be involved in synaptic remodeling after cochlear lesion [156]. Either overactivation or excessive inhibition of MMPs can lead to multiple disorders like carcinoma invasion and migration [157]. RNA sequencing data reveal that MMPs are upregulated in the acute phase after noise exposure and decreased gradually over time. A short-term administration of doxycycline, an inhibitor of MMPs, can attenuate noise-induced hearing loss while a seven-day application regimen exacerbates the hair cell death reversely [158]. MMPs are regulated by cysteinyl leukotriene and its type 1 receptor (CysLTR1), which is also increased in the cochlea after acoustic overstimulation. A four-day application of montelukast, a leukotriene receptor antagonist, can ameliorate NIHL damage [159].

3.7.2. Pannexins

Like the well-researched connexin channels, pannexin protein is also involved in the intracellular communication channel formation allowing the passage of the small molecules and ions. Panx3 is one of the main kinds of pannexin protein expressed in the cochlea [160]. A previous study [161] has proved that genetic depletion of paxn3 has no impact on the proper morphogenesis of the inner ear and hearing though the cochlear bone is slightly impaired. Strikingly, the panx3 knockout mice show decreased susceptibility to NIHL while the mechanism underlying its acoustic protective effect still requires further exploration.

Up to now, there are more than 30 gene variations reported to be relevant to NIHL in animal studies or human epidemiology investigations.

4.1. Oxidative Stress and DNA Repair-Related Gene Variations

Since oxidative stress contributes to the pathogenesis of NIHL, mutations of multiple genes involving in the antioxidative system have been proved to alter noise susceptibility. Catalase (CAT), superoxide dismutase (SOD2), and the antioxidant paraoxonase (PON) are three main proteins playing important roles in scavenging free radicals; mutation of which weakens the intracellular defensive ability against noise-induced oxidative damage [71, 162, 163]. NFL2E2 (also known as Nrf2) is a vital transcriptional factor regulating various antioxidative protein expressions such as HO-1, CAT, SOD, and GPx [65]. Polymorphisms of NFL2E2 (rs6726395 and rs77684420) have been confirmed as related to genetic vulnerability for NIHL in a Chinese population-based study [164]. Other genes, like NOX3 encoding NADPH oxidase-3 catalyzing the generation of superoxide [165], HSPA1L encoding chaperons assisting antioxidative proteins to fold correctly [166], and GST (glutathione S-transferase) family [167, 168] which participate in the metabolism of an intracellular antioxidant GSH, have been reported as NIHL-related genes.

Moreover, free radicals and lipid peroxide induced by acoustic trauma could do harm to DNA integrity and might cause mutations of certain sequences. APE1 [169] and OGG1 [170], encoding DNA repair enzymes to remove specific abnormal bases, are found to be associated with NIHL susceptibility as well.

4.2. Apoptosis-Related Gene Variations

Another case-control study [171] involving Chinese workers with or without noise exposure history identifies two SNPs of CASP3 (rs1049216 and rs6948) significantly correlated to decreased NIHL risk, due to impaired apoptosis of hair cells since caspase3 serves as the central role of apoptosis induction.

4.3. Gap Junction-Related Gene Variations

Connexin 26, which is encoded by GJB2, is involved in the gap junction establishment between hair cells, allowing intercellular communications of ions and other small molecules [172, 173]. GJB2 SNP (rs3751385) is identified as a NIHL susceptible genetic mutation in a study applied in Polish workers [174]. Meanwhile, another study including Chinese workers reports that GJB2 SNP (rs137852540) combined with SOD2 and CAT mutations increased the vulnerability to NIHL [162]. The correlation between GJB mutation and NIHL vulnerability is also confirmed in Cx26 knockdown mice [174].

4.4. Potassium Channel-Related Gene Variations

Gene polymorphisms associated with K ion circulation in the inner ear are also associated with resistance to noise-induced hearing loss. KCNQ1/KCNE1 variation affecting potassium recycling is identified related to NIHL [175, 176]. Mutations of other potassium channel-related genes like KCNQ4 [175], KCNJ10 [176], and KCNMA1 [177] are also related to NIHL vulnerability. Potassium channels located in the outer hair cells in the cochlea which are responsible for the K+ influx regulate the excitability of OHCs. Reportedly, the potassium concentration in the cochlear endolymph of the guinea pig is upregulated shortly after acoustic injury [141, 178]. However, the exact mechanism behind potassium circulation disruption and NIHL is still lack of strong evidence.

4.5. Tip-Link-Related Gene Variations

The maturation of stereocilia in the hair cells is vital for hearing onset because it is where mechanical signals of sound waves are transformed into electrical signals that could be transported through hair cells and neurons. Tip-link, made of cadherins, plays an important part in the maintenance of ordered structure of stereocilia. A study revealed that mutations of PCDH15 and CDH23, two genes encoding cadherins for the integrity of stereocilia especially tip-link, are related to susceptibility to NIHL [179, 180].

4.6. Others

The purinergic receptor 2 (P2X2 receptor) is highly expressed in the cochlear sensory epithelium, especially in supporting cells of the greater epithelial ridge. P2X2 receptor can be activated by ATP [181] which is released from hair cells through connexins, and plays an important role in the development of the cochlea and hearing function [182]. A mutation of P2X2 gene (c.178G>T) is found responsible for progressive hearing loss and NIHL susceptibility in a Chinese family [183].

Another genome-wide association study suggested that AUTS2 SNP (rs35075890) and PTPRN2 SNP (rs10081191) are associated with NIHL vulnerability [184], which are commonly thought to be related to mental disorders and metabolic diseases according to previous studies [185].

There are quite more genes, with multiple physiological functions, reported to be NIHL-associated genetic factors, while the exact roles of which in the pathogenesis of NIHL still require deeper explorations (see more details in Table 1).


ClassGene nameVariationsFunction

Oxidative stressNOX3NADPH oxidase-3rs33652818 [165]Generation of superoxide (O2⋅-)
CATCatalasers7943316 [162, 163]Hydrogen peroxide decomposition
GSTM1Glutathione S-transferase mu 1Null [167, 168]GSH metabolism
GSTP1Glutathione S-transferase pi 1Ile (105)/Ile (105) [167, 168]GSH metabolism
GSTT1Glutathione S-transferase theta 1Null [167, 168]GSH metabolism
NFL2E2Nuclear factor erythroid-derived 2-like 2rs6726395
rs77684420 [164]
Transcriptional factor regulating various antioxidative protein expression
HSPA1LHeat shock protein family A member 1 likers2227956 [166]Antioxidative protein stabilizer
PON2Paraoxonase 2S311C [71]Antioxidative protein
SOD2Superoxide dismutase 2IVS3-23T/G
IVS3-60T/G [71]
Catalyzing the destruction of free radical

ApoptosisCASP3Caspase3rs1049216
rs6948 [171]
Intracellular apoptosis promoter

DNA methylationDNMT1DNA methyltransferase 1rs2228611 [186]DNA methylation
DNMT3ADNA methyltransferase 3 alphars749131 [186]DNA methylation

Gap junctionGJB1Gap junction protein beta1rs1997625 [176]Gap junction channels
GJB2Gap junction protein beta2rs3751385 [162, 176]Gap junction channels
GJB4Gap junction protein beta4rs755931 [176]Gap junction channels

DNA repairAPE1Apurinic/apyrimidinic endodeoxy-ribonuclease 1T1349G
T656G [169]
Encoding the endonuclease, a DNA repair enzyme
OGG18-Oxoguanine DNA glycosylaseSer326Cys [170]DNA repair enzyme

Ion channelsKCNMA1Potassium calcium-activated channel subfamily M alpha1rs696211 [177]Ca2+-activated K+ channel
KCNE1Potassium voltage-gated channel subfamily E regulatory subunit 1rs2070358
rs1805128 [175, 176]
K+ channel
KCNJ10Potassium inwardly-rectifying channel subfamily J member 10rs1130183 [176]K+ channel
KCNQ1Potassium voltage-gated channel subfamily Q member 1rs7945327
rs11022922
rs718579
rs163171
rs2056892 [175, 176]
K+ channel
KCNQ4Potassium voltage-gated channel subfamily Q member 4rs4660468 [175]K+ channel

Stereocilia structurePCDH15Protocadherin related 15rs11004085
rs7095441 [179]
Encoding cadherin for the integrity of stereocilia, especially tip-link
CDH23Cadherin 23rs3752752 [180]Encoding cadherin for the integrity of stereocilia, especially tip-link
MYH14Myosin heavy chain 14rs667907
rs588035 [179]
Might contribute to tip-link integrity

OthersEYA4EYA transcriptional coactivator and phosphatase 4rs3813346 [187]Multifunctional transcriptional factor
FOXO3Forkhead box O3rs2802292
rs3777781
rs212769 [188]
Multifunctional transcriptional factor
GRHL2Grainyhead-like 2rs611419 [189, 190]Multifunctional transcriptional factor
HOTAIRHOX transcript antisense RNArs4759314 [191]Regulatory lncRNA
MYO1AMyosin 1ars1552245 [177]Actin-based molecular motors
NOTCH1Notch receptor 1rs3124594
rs3124603 [192]
Notch signaling transduction
NCLNucleolinrs7598759 [193]Ribosome biogenesis
P2RX2Purinergic receptor P2X2V60L [183]Purinergic signaling transduction
AUTS2Autism susceptibility candidate 2rs35075890 [185]Multifunctions
PTPRN2Protein tyrosine phosphatase receptor type N2rs10081191 [184]Multifunctions

5. Therapeutics

It is widely acknowledged the lack of approved medications for NIHL treatment, and recent pharmaceutical explorations are heralding a new era in the field.

5.1. Approved Medications

Clinically, few medications have been identified as effective except glucocorticoid for NIHL. Glucocorticoid has been proved to exhibit various protective effects against NIHL, highlighted by its anti-inflammatory activity via inhibiting the synthesis and release of inflammatory molecules like prostaglandins and leukotrienes. Dexamethasone, as the most commonly used glucocorticoid in clinical practice, was administered postintense white noise with intratympanic or intraperitoneal injection. And two routines of administration show similar hearing recovery effects; both are significantly better than the saline group [194].

5.2. Drugs in Clinical Trials

The phase 2 trial report of ebselen has assessed its safety and efficacy on NIHL. Ebselen, the GPx1 mimic, aims at oxidative stress reduction. In this randomized, double-blind, placebo-controlled phase 2 trial, subjects receiving 400 mg ebselen show significantly protective effect on transient noise-induced hearing impairment with no side effects reported [195].

5.3. Potential Medications
5.3.1. Medications Targeting Oxidative Stress

Qter, the artificial analog of an endogenous antioxidant coenzyme Q10, was administered systematically to noise-exposed mice and significantly reduced the threshold shift after acoustic trauma and promoted outer hair cell survival [196]. Moreover, the dendrites of spiral ganglion cells and cortical neuronal morphology are significantly restored by Qter application for its role involved in free radicals scavenging and regeneration of antioxidants like reduced glutathione (GSH)[197]. And redox homeostasis is maintained by Qter treatment demonstrated by reduction of 4-HNE or DHE (the markers of lipid peroxidation) immunostaining-positive cells in the cochleae.

Parallel to Qter, a peptide derived from human telomerase called GV1001 attenuates sensory hair cell death targeting the noise-induced excessive ROS/RNS accumulation, as suggested by the byproducts of lipid peroxidation (4-HNE) and protein nitration (3-NT) [58]. Moreover, GV1001 can also ameliorate kanamycin-induced hearing loss in mice, indicating that excessive ROS/RNS and its downstream cascades like inflammation and apoptosis underlie the sharing pathological contributors for noise and aminoglycoside-induced ototoxicity. Taking into consideration previous studies regarding the therapeutic effects of GV1001, we hypothesize that GV1001 might also exert otoprotective effects against NIHL, because excessive ROS/RNS generation is thought to underlie the causative mechanisms of NIHL.

The systematical administration of methylene blue prior to noise trauma promotes the acoustic hair cell survival via ameliorating the oxidative stress-induced dysfunction of respiratory electron transport chain, featured by the reservation of complex IV activity and ATP production [198]. Moreover, methylene blue induces generation of neurotrophin-3 (NT-3) to preserve the synaptic ribbons around inner hair cells upon noise exposure [199].

5.3.2. Medications Targeting Inflammation

Avenanthramide-C (AVN-C), a natural flavonoid purified from oats, has shown anti-inflammatory and antioxidant activities in in vitro experiments. Notably, AVN-C has great water solubility and blood-labyrinth barrier permeability, suggesting pharmaceutical potential for NIHL treatment. Researchers have found that peritoneal injection of AVN-C protects hair cells from noise trauma by increasing antioxidant defense and decreasing proinflammatory cytokines like IL-1β and Tnf [200].

5.4. Medications Targeting Hearing Protective Genes

Isl1, which is highly expressed in prosensory region during otocyst development and no longer expressed in the postnatal cochlea, attenuates noise-triggered hair cell loss when artificially overexpressed specifically in postnatal hair cells. Though the exact mechanism behind the protective effect of Isl1 is not fully understood, it proposes a bold hypothesis that overexpression of acoustic progenitor developmental genes in the adult cochlea might increase the hair cell defense system against noise stress [201].

5.5. Emerging Nanoparticle Medications

Nanomedication, as a newly emerged therapy, was applied in the NIHL treatment. Nanosystems, including polyethylene glycol- (PEG-) coated poly lactic acid (PLA) nanoparticles and zeolitic imidazolate nanoparticles, were invented and applied to deliver steroid drugs to the inner ear. They show significant protective effect, even better than free steroid drugs, when administered systematically with better stability and biocompatibility [202, 203]. However, the efficacy and safety of nanoparticle-based medications still need further verification.

6. Conclusions

In this article, we systematically and comprehensively reviewed the epidemiology, mechanical and molecular pathogenesis, and therapeutic inventions about NIHL. Oxidative stress, inflammation, calcium overload, glutamate excitotoxicity, and energy metabolism are the main contributors to NIHL up to now. These pharmaceutical exploring studies not only shed light on the clinical treatment for NIHL but also make further steps on the systematical understanding of NIHL pathogenesis.

Controversies are engendered on certain disputations of NIHL: Firstly, the oxidative stress in supporting cells upon acoustic trauma has been verified, but how to promote hair cell survival through regulating supporting cells is still blank. Secondly, the excitotoxicity of excessive glutamate exacerbates the destruction of acoustic nerve while Vglut3 knockout mice show impaired neural fiber recovery. Similarly, administration of BDNF ameliorates NIHL, but depletion of Bdnf receptor gene also shows protective effect by inhibiting glutamate release. Therefore, given the complexity of glutamate and neurotrophins, what is the proper way of modulating glutamate and neurotrophins for the maximum protective effect? Thirdly, because of the blood-perilymph barrier, most medications administered systematically are hard to penetrate into the cochlea. The development of nanomedication would alter the stability and permeability of drugs, which might bring hope to the emergency of more efficacious and less toxic medication. Moreover, with the research progresses in the field of regeneration of cochlear hair cells and neural fibers [24, 204208], NIHL might be curable one day in the future.

Conflicts of Interest

The authors claim that there are no conflicts of interest.

Acknowledgments

This work was supported by the National Natural Science Foundation of China (82071049, 81771010, and 81570911).

References

  1. Y. Liu, J. Qi, X. Chen et al., “Critical role of spectrin in hearing development and deafness,” Science Advances, vol. 5, no. 4, 2019. View at: Publisher Site | Google Scholar
  2. Y. Wang, J. Li, X. Yao et al., “Loss of CIB2 causes profound hearing loss and abolishes mechanoelectrical transduction in mice,” Frontiers in Molecular Neuroscience, vol. 10, p. 401, 2017. View at: Publisher Site | Google Scholar
  3. J. Qi, Y. Liu, C. Chu et al., “A cytoskeleton structure revealed by super-resolution fluorescence imaging in inner ear hair cells,” Cell Discovery, vol. 5, no. 1, p. 12, 2019. View at: Publisher Site | Google Scholar
  4. Q. Fang, Y. Zhang, P. da et al., “Deletion of Limk1 and Limk2 in mice does not alter cochlear development or auditory function,” Scientific Reports, vol. 9, no. 1, article 39769, p. 3357, 2019. View at: Publisher Site | Google Scholar
  5. S. Zhang, Y. Zhang, Y. Dong et al., “Knockdown of Foxg1 in supporting cells increases the trans-differentiation of supporting cells into hair cells in the neonatal mouse cochlea,” Cellular and Molecular Life Sciences : CMLS, vol. 77, no. 7, article 3291, pp. 1401–1419, 2020. View at: Publisher Site | Google Scholar
  6. C. Cheng, Y. Wang, L. Guo et al., “Age-related transcriptome changes in Sox2+ supporting cells in the mouse cochlea,” Stem Cell Research & Therapy, vol. 10, no. 1, article 1437, p. 365, 2019. View at: Publisher Site | Google Scholar
  7. X. Lu, S. Sun, J. Qi et al., “Bmi1 regulates the proliferation of cochlear supporting cells via the canonical Wnt signaling pathway,” Molecular Neurobiology, vol. 54, no. 2, article 9686, pp. 1326–1339, 2017. View at: Publisher Site | Google Scholar
  8. S. Zhang, R. Qiang, Y. Dong et al., “Hair cell regeneration from inner ear progenitors in the mammalian cochlea,” American Journal of Stem Cells, vol. 9, no. 3, pp. 25–35, 2020. View at: Google Scholar
  9. B. Cox, R. Chai, A. Lenoir et al., “Spontaneous hair cell regeneration in the neonatal mouse cochlea in vivo,” Development (Cambridge, England), vol. 141, no. 4, pp. 816–829, 2014. View at: Publisher Site | Google Scholar
  10. Z. He, S. Y. Zou, M. Li et al., “The nuclear transcription factor FoxG1 affects the sensitivity of mimetic aging hair cells to inflammation by regulating autophagy pathways,” Redox Biology, vol. 28, article 101364, 2020. View at: Publisher Site | Google Scholar
  11. P. Jiang, S. Zhang, C. Cheng et al., “The roles of exosomes in visual and auditory systems,” Frontiers in Bioengineering and Biotechnology, vol. 8, p. 525, 2020. View at: Publisher Site | Google Scholar
  12. F. Qian, X. Wang, Z. Yin et al., “The slc4a2b gene is required for hair cell development in zebrafish,” Aging, vol. 12, no. 19, article 103840, pp. 18804–18821, 2020. View at: Publisher Site | Google Scholar
  13. J. Lv, X. Fu, Y. Li et al., “Deletion of Kcnj16 in mice does not alter auditory function,” Frontiers in Cell and Development Biology, vol. 9, article 630361, 2021. View at: Publisher Site | Google Scholar
  14. W. Clark and B. Bohne, “Effects of noise on hearing,” JAMA, vol. 281, no. 17, pp. 1658-1659, 1999. View at: Publisher Site | Google Scholar
  15. “Noise and hearing loss,” Lancet (London, England), vol. 338, no. 8758, pp. 21-22, 1991. View at: Google Scholar
  16. The Cochrane Collaboration, E. Kateman, J. H. Verbeek et al., “Interventions to prevent occupational noise induced hearing loss,” The Cochrane Database of Systematic Reviews, vol. 7, 2017. View at: Publisher Site | Google Scholar
  17. The Cochrane Collaboration, J. H. Verbeek, E. Kateman, T. C. Morata, W. Dreschler, and B. Sorgdrager, “Interventions to prevent occupational noise induced hearing loss,” The Cochrane Database of Systematic Reviews, vol. 3, 2009. View at: Publisher Site | Google Scholar
  18. E. Lynch and J. Kil, “Compounds for the prevention and treatment of noise-induced hearing loss,” Drug Discovery Today, vol. 10, no. 19, pp. 1291–1298, 2005. View at: Publisher Site | Google Scholar
  19. A. Fetoni, F. Paciello, R. Rolesi, G. Paludetti, and D. Troiani, “Targeting dysregulation of redox homeostasis in noise-induced hearing loss: oxidative stress and ROS signaling,” Free Radical Biology & Medicine, vol. 135, pp. 46–59, 2019. View at: Publisher Site | Google Scholar
  20. G. Harding, B. Bohne, and M. Ahmad, “DPOAE level shifts and ABR threshold shifts compared to detailed analysis of histopathological damage from noise,” Hearing Research, vol. 174, no. 1-2, pp. 158–171, 2002. View at: Publisher Site | Google Scholar
  21. M. Liberman, “Noise-induced hearing loss: permanent versus temporary threshold shifts and the effects of hair cell versus neuronal degeneration,” Advances in Experimental Medicine and Biology, vol. 875, pp. 1–7, 2016. View at: Publisher Site | Google Scholar
  22. T. Wang, R. Chai, G. S. Kim et al., “Lgr5+ cells regenerate hair cells via proliferation and direct transdifferentiation in damaged neonatal mouse utricle,” Nature Communications, vol. 6, no. 1, p. 6613, 2015. View at: Publisher Site | Google Scholar
  23. W. Li, D. You, Y. Chen, R. Chai, and H. Li, “Regeneration of hair cells in the mammalian vestibular system,” Frontiers in Medicine, vol. 10, no. 2, pp. 143–151, 2016. View at: Publisher Site | Google Scholar
  24. S. Zhang, D. Liu, Y. Dong et al., “Frizzled-9+ supporting cells are progenitors for the generation of hair cells in the postnatal mouse cochlea,” Frontiers in Molecular Neuroscience, vol. 12, p. 184, 2019. View at: Publisher Site | Google Scholar
  25. Y. Zhang, L. Guo, X. Lu et al., “Characterization of Lgr6+ cells as an enriched population of hair cell progenitors compared to Lgr5+ cells for hair cell generation in the neonatal mouse cochlea,” Frontiers in Molecular Neuroscience, vol. 11, p. 147, 2018. View at: Publisher Site | Google Scholar
  26. Y. Chen, X. Lu, L. Guo et al., “Hedgehog signaling promotes the proliferation and subsequent hair cell formation of progenitor cells in the neonatal mouse cochlea,” Frontiers in Molecular Neuroscience, vol. 10, p. 426, 2017. View at: Publisher Site | Google Scholar
  27. B. Wilson, D. L. Tucci, M. H. Merson, and G. M. O'Donoghue, “Global hearing health care: new findings and perspectives,” Lancet (London, England), vol. 390, no. 10111, pp. 2503–2515, 2017. View at: Publisher Site | Google Scholar
  28. H. Zhuang, J. Yang, Z. Huang et al., “Accelerated age-related decline in hippocampal neurogenesis in mice with noise-induced hearing loss is associated with hippocampal microglial degeneration,” Aging, vol. 12, no. 19, article 103898, pp. 19493–19519, 2020. View at: Publisher Site | Google Scholar
  29. S. Park, S. A. Back, K. H. Park et al., “Comparison of functional and morphologic characteristics of mice models of noise-induced hearing loss,” Auris, Nasus, Larynx, vol. 40, no. 1, pp. 11–17, 2013. View at: Publisher Site | Google Scholar
  30. W. Han, J. O. Shin, J. H. Ma et al., “Distinct roles of stereociliary links in the nonlinear sound processing and noise resistance of cochlear outer hair cells,” Proceedings of the National Academy of Sciences of the United States of America, vol. 117, no. 20, pp. 11109–11117, 2020. View at: Publisher Site | Google Scholar
  31. C. Zhu, C. Cheng, Y. Wang et al., “Loss of ARHGEF6 causes hair cell stereocilia deficits and hearing loss in mice,” Frontiers in Molecular Neuroscience, vol. 11, p. 362, 2018. View at: Publisher Site | Google Scholar
  32. J. Qi, L. Zhang, F. Tan et al., “Espin distribution as revealed by super-resolution microscopy of stereocilia,” American Journal of Translational Research, vol. 12, no. 1, pp. 130–141, 2020. View at: Google Scholar
  33. J. Jensen, A. C. Lysaght, M. C. Liberman, K. Qvortrup, and K. M. Stankovic, “Immediate and delayed cochlear neuropathy after noise exposure in pubescent mice,” PLoS One, vol. 10, no. 5, article e0125160, 2015. View at: Publisher Site | Google Scholar
  34. L. Shi, K. Liu, H. Wang et al., “Noise induced reversible changes of cochlear ribbon synapses contribute to temporary hearing loss in mice,” Acta Oto-Laryngologica, vol. 135, no. 11, pp. 1093–1102, 2015. View at: Publisher Site | Google Scholar
  35. W. Liu, X. Xu, Z. Fan et al., “Wnt signaling activates TP53-induced glycolysis and apoptosis regulator and protects against cisplatin-induced spiral ganglion neuron damage in the mouse cochlea,” Antioxidants & Redox Signaling, vol. 30, no. 11, pp. 1389–1410, 2019. View at: Publisher Site | Google Scholar
  36. W. Yan, W. Liu, J. Qi et al., “A three-dimensional culture system with Matrigel promotes purified spiral ganglion neuron survival and function in vitro,” Molecular Neurobiology, vol. 55, no. 3, pp. 2070–2084, 2018. View at: Publisher Site | Google Scholar
  37. R. Guo, X. Ma, M. Liao et al., “Development and application of cochlear implant-based electric-acoustic stimulation of spiral ganglion neurons,” ACS Biomaterials Science & Engineering, vol. 5, no. 12, pp. 6735–6741, 2019. View at: Publisher Site | Google Scholar
  38. M. Mayorga, “The pathology of primary blast overpressure injury,” Toxicology, vol. 121, no. 1, pp. 17–28, 1997. View at: Publisher Site | Google Scholar
  39. J. Patterson and R. Hamernik, “Blast overpressure induced structural and functional changes in the auditory system,” Toxicology, vol. 121, no. 1, pp. 29–40, 1997. View at: Publisher Site | Google Scholar
  40. S. Shin, A. R. Lyu, S. H. Jeong, T. H. Kim, M. J. Park, and Y. H. Park, “Acoustic trauma modulates cochlear blood flow and vasoactive factors in a rodent model of noise-induced hearing loss,” International Journal of Molecular Sciences, vol. 20, no. 21, p. 5316, 2019. View at: Publisher Site | Google Scholar
  41. P. Littlefield and D. Brungart, “Long-term sensorineural hearing loss in patients with blast-induced tympanic membrane perforations,” Ear and Hearing, vol. 41, no. 1, pp. 165–172, 2020. View at: Publisher Site | Google Scholar
  42. K. Mizutari, “Update on treatment options for blast-induced hearing loss,” Current Opinion in Otolaryngology & Head and Neck Surgery, vol. 27, no. 5, pp. 376–380, 2019. View at: Publisher Site | Google Scholar
  43. T. Nicotera, B. Hu, and D. Henderson, “The caspase pathway in noise-induced apoptosis of the chinchilla cochlea,” Journal of the Association for Research in Otolaryngology: JARO, vol. 4, no. 4, pp. 466–477, 2003. View at: Publisher Site | Google Scholar
  44. H. Zheng, J. Chen, and S. Sha, “Receptor-interacting protein kinases modulate noise-induced sensory hair cell death,” Cell Death & Disease, vol. 5, no. 5, article e1262, 2014. View at: Publisher Site | Google Scholar
  45. K. Ohlemiller, J. Wright, and L. Dugan, “Early elevation of cochlear reactive oxygen species following noise exposure,” Audiology & Neuro-Otology, vol. 4, no. 5, pp. 229–236, 1999. View at: Publisher Site | Google Scholar
  46. J. Cobley, “Mechanisms of mitochondrial ROS production in assisted reproduction: the known, the unknown, and the intriguing,” Antioxidants (Basel, Switzerland), vol. 9, no. 10, p. 933, 2020. View at: Publisher Site | Google Scholar
  47. W. Zhang, H. Xiong, J. Pang et al., “Nrf2 activation protects auditory hair cells from cisplatin-induced ototoxicity independent on mitochondrial ROS production,” Toxicology Letters, vol. 331, pp. 1–10, 2020. View at: Publisher Site | Google Scholar
  48. S. Chong, I. Low, and S. Pervaiz, “Mitochondrial ROS and involvement of Bcl-2 as a mitochondrial ROS regulator,” Mitochondrion, vol. 19, pp. 39–48, 2014. View at: Publisher Site | Google Scholar
  49. C. Ojano-Dirain, P. Antonelli, and C. G. le Prell, “Mitochondria-targeted antioxidant MitoQ reduces gentamicin-induced ototoxicity,” American Neurotology Society [and] European Academy of Otology and Neurotology, vol. 35, no. 3, pp. 533–539, 2014. View at: Publisher Site | Google Scholar
  50. Z. He, L. Guo, Y. Shu et al., “Autophagy protects auditory hair cells against neomycin-induced damage,” Autophagy, vol. 13, no. 11, pp. 1884–1904, 2017. View at: Publisher Site | Google Scholar
  51. S. Gao, C. Cheng, M. Wang et al., “Blebbistatin inhibits neomycin-induced apoptosis in hair cell-like HEI-OC-1 cells and in cochlear hair cells,” Frontiers in Cellular Neuroscience, vol. 13, p. 590, 2020. View at: Publisher Site | Google Scholar
  52. S. Sun, M. Sun, Y. Zhang et al., “In vivo overexpression of X-linked inhibitor of apoptosis protein protects against neomycin-induced hair cell loss in the apical turn of the cochlea during the ototoxic-sensitive period,” Frontiers in Cellular Neuroscience, vol. 8, p. 248, 2014. View at: Publisher Site | Google Scholar
  53. Z. Zhong, X. Fu, H. Li et al., “Citicoline protects auditory hair cells against neomycin-induced damage,” Frontiers in Cell and Developmental Biology, vol. 8, p. 712, 2020. View at: Publisher Site | Google Scholar
  54. Y. Zhang, W. Li, Z. He et al., “Pre-treatment with fasudil prevents neomycin-induced hair cell damage by reducing the accumulation of reactive oxygen species,” Frontiers in Molecular Neuroscience, vol. 12, p. 264, 2019. View at: Publisher Site | Google Scholar
  55. X. Yu, W. Liu, Z. Fan et al., “c-Myb knockdown increases the neomycin-induced damage to hair-cell-like HEI- OC1 cells in vitro,” Scientific Reports, vol. 7, no. 1, article 41094, 2017. View at: Publisher Site | Google Scholar
  56. M. Guan, Q. Fang, Z. He et al., “Inhibition of ARC decreases the survival of HEI-OC-1 cells after neomycin damage in vitro,” Oncotarget, vol. 7, no. 41, article 11336, pp. 66647–66659, 2016. View at: Publisher Site | Google Scholar
  57. K. Prasad and S. Bondy, “Increased oxidative stress, inflammation, and glutamate: potential preventive and therapeutic targets for hearing disorders,” Mechanisms of Ageing and Development, vol. 185, article 111191, 2020. View at: Publisher Site | Google Scholar
  58. S. Lee, J. J. Han, S. Y. Lee et al., “Outcomes of peptide vaccine GV1001 treatment in a murine model of acute noise-induced hearing loss,” Antioxidants (Basel, Switzerland), vol. 9, no. 2, p. 112, 2020. View at: Publisher Site | Google Scholar
  59. A. Li, D. You, W. Li et al., “Novel compounds protect auditory hair cells against gentamycin-induced apoptosis by maintaining the expression level of H3K4me2,” Drug Delivery, vol. 25, no. 1, pp. 1033–1043, 2018. View at: Publisher Site | Google Scholar
  60. Z. He, S. Sun, M. Waqas et al., “Reduced TRMU expression increases the sensitivity of hair-cell-like HEI-OC-1 cells to neomycin damage in vitro,” Scientific Reports, vol. 6, no. 1, article 29621, 2016. View at: Publisher Site | Google Scholar
  61. A. Fetoni, R. Rolesi, F. Paciello et al., “Styrene enhances the noise induced oxidative stress in the cochlea and affects differently mechanosensory and supporting cells,” Free Radical Biology & Medicine, vol. 101, pp. 211–225, 2016. View at: Publisher Site | Google Scholar
  62. P. Wenzel, S. Kossmann, T. Münzel, and A. Daiber, “Redox regulation of cardiovascular inflammation - immunomodulatory function of mitochondrial and Nox-derived reactive oxygen and nitrogen species,” Free Radical Biology & Medicine, vol. 109, pp. 48–60, 2017. View at: Publisher Site | Google Scholar
  63. S. Morioka, H. Sakaguchi, T. Yamaguchi et al., “Hearing vulnerability after noise exposure in a mouse model of reactive oxygen species overproduction,” Journal of Neurochemistry, vol. 146, no. 4, pp. 459–473, 2018. View at: Publisher Site | Google Scholar
  64. M. Galicia-Moreno, S. Lucano-Landeros, H. C. Monroy-Ramirez et al., “Roles of Nrf2 in liver diseases: molecular, pharmacological, and epigenetic aspects,” Antioxidants (Basel, Switzerland), vol. 9, no. 10, p. 980, 2020. View at: Publisher Site | Google Scholar
  65. A. Cuadrado, A. I. Rojo, G. Wells et al., “Therapeutic targeting of the NRF2 and KEAP1 partnership in chronic diseases,” Drug Discovery, vol. 18, no. 4, pp. 295–317, 2019. View at: Publisher Site | Google Scholar
  66. D. Moretti, S. Tambone, M. Cerretani et al., “NRF2 activation by reversible KEAP1 binding induces the antioxidant response in primary neurons and astrocytes of a Huntington’s disease mouse model,” Free Radical Biology & Medicine, vol. 162, pp. 243–254, 2021. View at: Publisher Site | Google Scholar
  67. K. Hayashi, K. Dan, F. Goto et al., “The autophagy pathway maintained signaling crosstalk with the Keap1-Nrf2 system through p62 in auditory cells under oxidative stress,” Cellular Signalling, vol. 27, no. 2, pp. 382–393, 2015. View at: Publisher Site | Google Scholar
  68. A. Fetoni, F. Paciello, R. Rolesi et al., “Rosmarinic acid up-regulates the noise-activated Nrf2/HO-1 pathway and protects against noise-induced injury in rat cochlea,” Free Radical Biology & Medicine, vol. 85, pp. 269–281, 2015. View at: Publisher Site | Google Scholar
  69. L. Forsberg, U. de Faire, and R. Morgenstern, “Oxidative stress, human genetic variation, and disease,” Archives of Biochemistry and Biophysics, vol. 389, no. 1, pp. 84–93, 2001. View at: Publisher Site | Google Scholar
  70. Q. Chen, S. E. Reis, C. M. Kammerer et al., “Association between the severity of angiographic coronary artery disease and paraoxonase gene polymorphisms in the National Heart, Lung, and Blood Institute-sponsored Women’s Ischemia Syndrome Evaluation (WISE) study,” American Journal of Human Genetics, vol. 72, no. 1, pp. 13–22, 2003. View at: Publisher Site | Google Scholar
  71. G. Fortunato, E. Marciano, F. Zarrilli et al., “Paraoxonase and superoxide dismutase gene polymorphisms and noise-induced hearing loss,” Clinical Chemistry, vol. 50, no. 11, pp. 2012–2018, 2004. View at: Publisher Site | Google Scholar
  72. D. E. Coling, K. C. Y. Yu, D. Somand et al., “Effect of SOD1 overexpression on age- and noise-related hearing loss,” Free Radical Biology and Medicine, vol. 34, no. 7, pp. 873–880, 2003. View at: Publisher Site | Google Scholar
  73. K. Brown, S. Maqsood, J. Y. Huang et al., “Activation of SIRT3 by the NAD+ precursor nicotinamide riboside protects from noise-induced hearing loss,” Cell Metabolism, vol. 20, no. 6, pp. 1059–1068, 2014. View at: Publisher Site | Google Scholar
  74. J. Wang, Y. Yang, and W. Li, “SIRT3 deficiency increases mitochondrial oxidative stress and promotes migration of retinal pigment epithelial cells,” Experimental Biology and Medicine (Maywood, N.J.), vol. 246, no. 8, pp. 877–887, 2021. View at: Publisher Site | Google Scholar
  75. S. Someya, W. Yu, W. C. Hallows et al., “Sirt3 mediates reduction of oxidative damage and prevention of age-related hearing loss under caloric restriction,” Cell, vol. 143, no. 5, pp. 802–812, 2010. View at: Publisher Site | Google Scholar
  76. N. Mizushima and B. Levine, “Autophagy in human diseases,” The New England Journal of Medicine, vol. 383, no. 16, pp. 1564–1576, 2020. View at: Publisher Site | Google Scholar
  77. H. Zhou, X. Qian, N. Xu et al., “Disruption of Atg7-dependent autophagy causes electromotility disturbances, outer hair cell loss, and deafness in mice,” Cell Death & Disease, vol. 11, no. 10, p. 913, 2020. View at: Publisher Site | Google Scholar
  78. Y. Ding, W. Meng, W. Kong, Z. He, and R. Chai, “The role of FoxG1 in the inner ear,” Frontiers in Cell and Development Biology, vol. 8, article 614954, 2020. View at: Publisher Site | Google Scholar
  79. Z. He, Q. Fang, H. Li et al., “The role of FOXG1 in the postnatal development and survival of mouse cochlear hair cells,” Neuropharmacology, vol. 144, pp. 43–57, 2019. View at: Publisher Site | Google Scholar
  80. H. Li, Y. Song, Z. He et al., “Meclofenamic acid reduces reactive oxygen species accumulation and apoptosis, inhibits excessive autophagy, and protects hair cell-like HEI-OC1 cells from cisplatin-induced damage,” Frontiers in Cellular Neuroscience, vol. 12, p. 139, 2018. View at: Publisher Site | Google Scholar
  81. H. Yuan, X. Wang, K. Hill et al., “Autophagy attenuates noise-induced hearing loss by reducing oxidative stress,” Antioxidants & Redox Signaling, vol. 22, no. 15, pp. 1308–1324, 2015. View at: Publisher Site | Google Scholar
  82. P. Li, D. Bing, S. Wang et al., “Sleep deprivation modifies noise-induced cochlear injury related to the stress hormone and autophagy in female mice,” Frontiers in Neuroscience, vol. 13, p. 1297, 2019. View at: Publisher Site | Google Scholar
  83. S. Pattingre, L. Espert, M. Biard-Piechaczyk, and P. Codogno, “Regulation of macroautophagy by mTOR and Beclin 1 complexes,” Biochimie, vol. 90, no. 2, pp. 313–323, 2008. View at: Publisher Site | Google Scholar
  84. J. Defourny, A. Aghaie, I. Perfettini, P. Avan, S. Delmaghani, and C. Petit, “Pejvakin-mediated pexophagy protects auditory hair cells against noise-induced damage,” Proceedings of the National Academy of Sciences of the United States of America, vol. 116, no. 16, pp. 8010–8017, 2019. View at: Publisher Site | Google Scholar
  85. M. Fujioka, H. Okano, and K. Ogawa, “Inflammatory and immune responses in the cochlea: potential therapeutic targets for sensorineural hearing loss,” Frontiers in Pharmacology, vol. 5, p. 287, 2014. View at: Publisher Site | Google Scholar
  86. T. Okano, T. Nakagawa, T. Kita et al., “Bone marrow-derived cells expressing Iba1 are constitutively present as resident tissue macrophages in the mouse cochlea,” Journal of Neuroscience Research, vol. 86, no. 8, pp. 1758–1767, 2008. View at: Publisher Site | Google Scholar
  87. Y. Hayashi, H. Suzuki, W. Nakajima et al., “Cochlear supporting cells function as macrophage-like cells and protect audiosensory receptor hair cells from pathogens,” Scientific Reports, vol. 10, no. 1, article 63654, p. 6740, 2020. View at: Publisher Site | Google Scholar
  88. K. Hirose, C. M. Discolo, J. R. Keasler, and R. Ransohoff, “Mononuclear phagocytes migrate into the murine cochlea after acoustic trauma,” The Journal of Comparative Neurology, vol. 489, no. 2, pp. 180–194, 2005. View at: Publisher Site | Google Scholar
  89. S. Tornabene, K. Sato, L. Pham, P. Billings, and E. M. Keithley, “Immune cell recruitment following acoustic trauma,” Hearing Research, vol. 222, no. 1-2, pp. 115–124, 2006. View at: Publisher Site | Google Scholar
  90. M. Fujioka, S. Kanzaki, H. J. Okano, M. Masuda, K. Ogawa, and H. Okano, “Proinflammatory cytokines expression in noise-induced damaged cochlea,” Journal of Neuroscience Research, vol. 83, no. 4, pp. 575–583, 2006. View at: Publisher Site | Google Scholar
  91. W. Wang, L. S. Zhang, A. K. Zinsmaier et al., “Neuroinflammation mediates noise-induced synaptic imbalance and tinnitus in rodent models,” PLoS Biology, vol. 17, no. 6, article e3000307, 2019. View at: Publisher Site | Google Scholar
  92. H. Satoh, G. S. Firestein, P. B. Billings, J. P. Harris, and E. M. Keithley, “Tumor necrosis factor-alpha, an initiator, and etanercept, an inhibitor of cochlear inflammation,” The Laryngoscope, vol. 112, no. 9, pp. 1627–1634, 2002. View at: Publisher Site | Google Scholar
  93. J. Rodrigues, A. L. L. Bachi, G. A. V. Silva et al., “New insights on the effect of TNF alpha blockade by gene silencing in noise-induced hearing loss,” International Journal of Molecular Sciences, vol. 21, no. 8, p. 2692, 2020. View at: Publisher Site | Google Scholar
  94. F. Paciello, A. di Pino, R. Rolesi et al., “Anti-oxidant and anti-inflammatory effects of caffeic acid: in vivo evidences in a model of noise-induced hearing loss,” Food and Chemical Toxicology: An International Journal Published for the British Industrial Biological Research Association, vol. 143, article 111555, 2020. View at: Publisher Site | Google Scholar
  95. Y. Zhang, D. Chen, L. Zhao et al., “Nfatc4 deficiency attenuates ototoxicity by suppressing Tnf-mediated hair cell apoptosis in the mouse cochlea,” Frontiers in Immunology, vol. 10, p. 1660, 2019. View at: Publisher Site | Google Scholar
  96. A. Dhukhwa, P. Bhatta, S. Sheth et al., “Targeting inflammatory processes mediated by TRPVI and TNF-α for treating noise-induced hearing loss,” Frontiers in Cellular Neuroscience, vol. 13, p. 444, 2019. View at: Publisher Site | Google Scholar
  97. D. Frenz, V. Galinovic-Schwartz, W. Liu, K. C. Flanders, and T. R. van de Water, “Transforming growth factor β1 is an epithelial-derived signal peptide that influences otic capsule formation,” Developmental Biology, vol. 153, no. 2, pp. 324–336, 1992. View at: Publisher Site | Google Scholar
  98. H. Kim, K. Y. Kang, J. G. Baek, H. C. Jo, and H. Kim, “Expression of TGFbeta family in the developing internal ear of rat embryos,” Journal of Korean Medical Science, vol. 21, no. 1, pp. 136–142, 2006. View at: Publisher Site | Google Scholar
  99. J. Okano, T. Takigawa, K. Seki, S. Suzuki, K. Shiota, and M. Ishibashi, “Transforming growth factor beta 2 promotes the formation of the mouse cochleovestibular ganglion in organ culture,” The International Journal of Developmental Biology, vol. 49, no. 1, pp. 23–31, 2005. View at: Publisher Site | Google Scholar
  100. C. Stolfi, E. Troncone, I. Marafini, and G. Monteleone, “Role of TGF-beta and Smad7 in gut inflammation, fibrosis and cancer,” Biomolecules, vol. 11, no. 1, p. 17, 2021. View at: Publisher Site | Google Scholar
  101. S. Wahl, “Transforming growth factor beta (TGF-beta) in inflammation: a cause and a cure,” Journal of Clinical Immunology, vol. 12, no. 2, pp. 61–74, 1992. View at: Publisher Site | Google Scholar
  102. A. Yoshimura, Y. Wakabayashi, and T. Mori, “Cellular and molecular basis for the regulation of inflammation by TGF-beta,” Journal of Biochemistry, vol. 147, no. 6, pp. 781–792, 2010. View at: Publisher Site | Google Scholar
  103. M. Nolte and C. Margadant, “Controlling immunity and inflammation through integrin-dependent regulation of TGF-β,” Trends in Cell Biology, vol. 30, no. 1, pp. 49–59, 2020. View at: Publisher Site | Google Scholar
  104. S. Murillo-Cuesta, L. Rodríguez-de la Rosa, J. Contreras et al., “Transforming growth factor β1 inhibition protects from noise-induced hearing loss,” Frontiers in Aging Neuroscience, vol. 7, p. 32, 2015. View at: Publisher Site | Google Scholar
  105. J. Moon, K. Nakahira, K. P. Chung et al., “NOX4-dependent fatty acid oxidation promotes NLRP3 inflammasome activation in macrophages,” Nature Medicine, vol. 22, no. 9, pp. 1002–1012, 2016. View at: Publisher Site | Google Scholar
  106. N. Sai, X. Shi, Y. Zhang et al., “Involvement of cholesterol metabolic pathways in recovery from noise-induced hearing loss,” Neural Plasticity, vol. 2020, Article ID 6235948, 17 pages, 2020. View at: Publisher Site | Google Scholar
  107. G. Zhang, H. Zheng, I. Pyykko, and J. Zou, “The TLR-4/NF-κB signaling pathway activation in cochlear inflammation of rats with noise-induced hearing loss,” Hearing Research, vol. 379, pp. 59–68, 2019. View at: Publisher Site | Google Scholar
  108. Y. Tahera, I. Meltser, P. Johansson et al., “NF-kappaB mediated glucocorticoid response in the inner ear after acoustic trauma,” Journal of Neuroscience Research, vol. 83, no. 6, pp. 1066–1076, 2006. View at: Publisher Site | Google Scholar
  109. I. Meltser, C. R. Cederroth, V. Basinou, S. Savelyev, G. S. Lundkvist, and B. Canlon, “TrkB-mediated protection against circadian sensitivity to noise trauma in the murine cochlea,” Current Biology : CB, vol. 24, no. 6, pp. 658–663, 2014. View at: Publisher Site | Google Scholar
  110. C. Cederroth, J. S. Park, V. Basinou et al., “Circadian regulation of cochlear sensitivity to noise by circulating glucocorticoids,” Current Biology: CB, vol. 29, no. 15, pp. 2477–2487.e6, 2019. View at: Publisher Site | Google Scholar
  111. N. Hakuba, K. Koga, K. Gyo, S. I. Usami, and K. Tanaka, “Exacerbation of noise-induced hearing loss in mice lacking the glutamate transporter GLAST,” The Journal of Neuroscience: The Official Journal of the Society for Neuroscience, vol. 20, no. 23, pp. 8750–8753, 2000. View at: Publisher Site | Google Scholar
  112. K. Kim, S. Payne, A. Yang-Hood et al., “Vesicular glutamatergic transmission in noise-induced loss and repair of cochlear ribbon synapses,” The Journal of Neuroscience: The Official Journal of the Society for Neuroscience, vol. 39, no. 23, pp. 4434–4447, 2019. View at: Publisher Site | Google Scholar
  113. Á. Chamorro, U. Dirnagl, X. Urra, and A. M. Planas, “Neuroprotection in acute stroke: targeting excitotoxicity, oxidative and nitrosative stress, and inflammation,” The Lancet. Neurology, vol. 15, no. 8, pp. 869–881, 2016. View at: Publisher Site | Google Scholar
  114. X. Dong, Y. Wang, and Z. Qin, “Molecular mechanisms of excitotoxicity and their relevance to pathogenesis of neurodegenerative diseases,” Acta Pharmacologica Sinica, vol. 30, no. 4, pp. 379–387, 2009. View at: Publisher Site | Google Scholar
  115. D. Bing, S. C. Lee, D. Campanelli et al., “Cochlear NMDA receptors as a therapeutic target of noise-induced tinnitus,” Cellular Physiology and Biochemistry: International Journal of Experimental Cellular Physiology, Biochemistry, and Pharmacology, vol. 35, no. 5, pp. 1905–1923, 2015. View at: Publisher Site | Google Scholar
  116. N. Hu, M. Rutherford, and S. Green, “Protection of cochlear synapses from noise-induced excitotoxic trauma by blockade of Ca2+-permeable AMPA receptors,” Proceedings of the National Academy of Sciences of the United States of America, vol. 117, no. 7, pp. 3828–3838, 2020. View at: Publisher Site | Google Scholar
  117. T. Hanada, “Ionotropic glutamate receptors in epilepsy: a review focusing on AMPA and NMDA receptors,” Biomolecules, vol. 10, no. 3, p. 464, 2020. View at: Publisher Site | Google Scholar
  118. A. Niedzielski and R. Wenthold, “Expression of AMPA, kainate, and NMDA receptor subunits in cochlear and vestibular ganglia,” The Journal of Neuroscience: The Official Journal of the Society for Neuroscience, vol. 15, no. 3, pp. 2338–2353, 1995. View at: Publisher Site | Google Scholar
  119. H. Tanaka, S. Y. Grooms, M. V. L. Bennett, and R. S. Zukin, “The AMPAR subunit GluR2: still front and center-stage1,” Brain Research, vol. 886, no. 1-2, pp. 190–207, 2000. View at: Publisher Site | Google Scholar
  120. M. Hollmann, M. Hartley, and S. Heinemann, “Ca2+ permeability of KA-AMPA--gated glutamate receptor channels depends on subunit composition,” Science (New York, N.Y.), vol. 252, no. 5007, pp. 851–853, 1991. View at: Publisher Site | Google Scholar
  121. T. Verdoorn, N. Burnashev, H. Monyer, P. Seeburg, and B. Sakmann, “Structural determinants of ion flow through recombinant glutamate receptor channels,” Science (New York, N.Y.), vol. 252, no. 5013, pp. 1715–1718, 1991. View at: Publisher Site | Google Scholar
  122. J. Sebe, S. Cho, L. Sheets, M. A. Rutherford, H. von Gersdorff, and D. W. Raible, “Ca2+-permeable AMPARs mediate glutamatergic transmission and excitotoxic damage at the hair cell ribbon synapse,” The Journal of Neuroscience: The Official Journal of the Society for Neuroscience, vol. 37, no. 25, pp. 6162–6175, 2017. View at: Publisher Site | Google Scholar
  123. B. Fritzsch, L. Tessarollo, E. Coppola, and L. F. Reichardt, “Neurotrophins in the ear: their roles in sensory neuron survival and fiber guidance,” Progress in Brain Research, vol. 146, pp. 265–278, 2004. View at: Publisher Site | Google Scholar
  124. G. Wan, M. E. Gómez-Casati, A. R. Gigliello, M. C. Liberman, and G. Corfas, “Neurotrophin-3 regulates ribbon synapse density in the cochlea and induces synapse regeneration after acoustic trauma,” eLife, vol. 3, 2014. View at: Publisher Site | Google Scholar
  125. M. Duan, K. Agerman, P. Ernfors, and B. Canlon, “Complementary roles of neurotrophin 3 and a N-methyl-D-aspartate antagonist in the protection of noise and aminoglycoside-induced ototoxicity,” Proceedings of the National Academy of Sciences of the United States of America, vol. 97, no. 13, pp. 7597–7602, 2000. View at: Publisher Site | Google Scholar
  126. A. Warnecke, J. Harre, H. Staecker et al., “Extracellular vesicles from human multipotent stromal cells protect against hearing loss after noise trauma in vivo,” Clinical and Translational Medicine, vol. 10, no. 8, article e262, 2020. View at: Publisher Site | Google Scholar
  127. A. Wise, R. Richardson, J. Hardman, G. Clark, and S. O'Leary, “Resprouting and survival of guinea pig cochlear neurons in response to the administration of the neurotrophins brain-derived neurotrophic factor and neurotrophin-3,” The Journal of Comparative Neurology, vol. 487, no. 2, pp. 147–165, 2005. View at: Publisher Site | Google Scholar
  128. D. Rejali, V. A. Lee, K. A. Abrashkin, N. Humayun, D. L. Swiderski, and Y. Raphael, “Cochlear implants and ex vivo BDNF gene therapy protect spiral ganglion neurons,” Hearing Research, vol. 228, no. 1-2, pp. 180–187, 2007. View at: Publisher Site | Google Scholar
  129. L. Pettingill, A. K. Wise, M. S. Geaney, and R. K. Shepherd, “Enhanced auditory neuron survival following cell-based BDNF treatment in the deaf guinea pig,” PLoS One, vol. 6, no. 4, article e18733, 2011. View at: Publisher Site | Google Scholar
  130. K. Fernandez, T. Watabe, M. Tong et al., “Trk agonist drugs rescue noise-induced hidden hearing loss,” JCI Insight, vol. 6, no. 3, 2021. View at: Publisher Site | Google Scholar
  131. A. Zuccotti, S. Kuhn, S. L. Johnson et al., “Lack of brain-derived neurotrophic factor hampers inner hair cell synapse physiology, but protects against noise-induced hearing loss,” The Journal of Neuroscience: The Official Journal of the Society for Neuroscience, vol. 32, no. 25, pp. 8545–8553, 2012. View at: Publisher Site | Google Scholar
  132. R. Fettiplace and J. Nam, “Tonotopy in calcium homeostasis and vulnerability of cochlear hair cells,” Hearing Research, vol. 376, pp. 11–21, 2019. View at: Publisher Site | Google Scholar
  133. I. Sziklai, “The significance of the calcium signal in the outer hair cells and its possible role in tinnitus of cochlear origin,” European Archives of Oto-Rhino-Laryngology, vol. 261, no. 10, pp. 517–525, 2004. View at: Publisher Site | Google Scholar
  134. E. Ferrary, P. Tran Ba Huy, N. Roinel, C. Bernard, and C. Amiel, “Calcium and the inner ear fluids,” Acta Oto-Laryngologica. Supplementum, vol. 460, pp. 13–17, 1988. View at: Publisher Site | Google Scholar
  135. H. Zuo, B. Cui, X. She, and M. Wu, “Changes in guinea pig cochlear hair cells after sound conditioning and noise exposure,” Journal of Occupational Health, vol. 50, no. 5, pp. 373–379, 2008. View at: Publisher Site | Google Scholar
  136. M. Castellano-Muñoz and A. Ricci, “Role of intracellular calcium stores in hair-cell ribbon synapse,” Frontiers in Cellular Neuroscience, vol. 8, p. 162, 2014. View at: Publisher Site | Google Scholar
  137. R. Fettiplace, “The role of calcium in hair cell transduction,” Society of General Physiologists Series, vol. 47, pp. 343–356, 1992. View at: Google Scholar
  138. A. Brandt, J. Striessnig, and T. Moser, “CaV1.3 channels are essential for development and presynaptic activity of cochlear inner hair cells,” The Journal of Neuroscience: The Official Journal of the Society for Neuroscience, vol. 23, no. 34, pp. 10832–10840, 2003. View at: Publisher Site | Google Scholar
  139. J. Fiolet and A. Baartscheer, “Cellular calcium homeostasis during ischemia; a thermodynamic approach,” Cardiovascular Research, vol. 45, no. 1, pp. 100–106, 2000. View at: Publisher Site | Google Scholar
  140. A. Fridberger, A. Flock, M. Ulfendahl, and B. Flock, “Acoustic overstimulation increases outer hair cell Ca2+ concentrations and causes dynamic contractions of the hearing organ,” Proceedings of the National Academy of Sciences of the United States of America, vol. 95, no. 12, pp. 7127–7132, 1998. View at: Publisher Site | Google Scholar
  141. K. Ikeda, J. Kusakari, and T. Takasaka, “Ionic changes in cochlear endolymph of the guinea pig induced by acoustic injury,” Hearing Research, vol. 32, no. 2-3, pp. 103–110, 1988. View at: Publisher Site | Google Scholar
  142. S. Minami, D. Yamashita, J. Schacht, and J. M. Miller, “Calcineurin activation contributes to noise-induced hearing loss,” Journal of Neuroscience Research, vol. 78, no. 3, pp. 383–392, 2004. View at: Publisher Site | Google Scholar
  143. M. Vicente-Torres and J. Schacht, “A BAD link to mitochondrial cell death in the cochlea of mice with noise-induced hearing loss,” Journal of Neuroscience Research, vol. 83, no. 8, pp. 1564–1572, 2006. View at: Publisher Site | Google Scholar
  144. F. Neumaier, M. Dibué-Adjei, J. Hescheler, and T. Schneider, “Voltage-gated calcium channels: determinants of channel function and modulation by inorganic cations,” Progress in Neurobiology, vol. 129, pp. 1–36, 2015. View at: Publisher Site | Google Scholar
  145. H. Shen, B. Zhang, J. H. Shin et al., “Prophylactic and therapeutic functions of T-type calcium blockers against noise-induced hearing loss,” Hearing Research, vol. 226, no. 1-2, pp. 52–60, 2007. View at: Publisher Site | Google Scholar
  146. U. Heinrich, J. Maurer, and W. Mann, “Alteration of loosely bound calcium in the guinea pig organ of Corti after treatment with diltiazem as calcium channel blocker,” European Archives of Oto-Rhino-Laryngology: official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology-Head and Neck Surgery, vol. 254, no. 5, pp. 223–229, 1997. View at: Publisher Site | Google Scholar
  147. K. Hill, H. Yuan, X. Wang, and S. H. Sha, “Noise-induced loss of hair cells and cochlear synaptopathy are mediated by the activation of AMPK,” The Journal of Neuroscience: The Official Journal of the Society for Neuroscience, vol. 36, no. 28, pp. 7497–7510, 2016. View at: Publisher Site | Google Scholar
  148. S. Vlajkovic, G. D. Housley, D. J. B. Muñoz et al., “Noise exposure induces up-regulation of ecto-nucleoside triphosphate diphosphohydrolases 1 and 2 in rat cochlea,” Neuroscience, vol. 126, no. 3, pp. 763–773, 2004. View at: Publisher Site | Google Scholar
  149. R. Thalmann, T. Miyoshi, and I. Thalmann, “The influence of ischemia upon the energy reserves of inner ear tissues,” The Laryngoscope, vol. 82, no. 12, pp. 2249–2272, 1972. View at: Publisher Site | Google Scholar
  150. W. W. Winder and D. M. Thomson, “Cellular energy sensing and signaling by AMP-activated protein kinase,” Cell Biochemistry and Biophysics, vol. 47, no. 3, pp. 332–347, 2007. View at: Publisher Site | Google Scholar
  151. F. Chen, H. W. Zheng, K. Hill, and S. H. Sha, “Traumatic noise activates Rho-family GTPases through transient cellular energy depletion,” The Journal of Neuroscience: The Official Journal of the Society for Neuroscience, vol. 32, no. 36, pp. 12421–12430, 2012. View at: Publisher Site | Google Scholar
  152. H. Sumimoto, R. Minakami, and K. Miyano, “Soluble regulatory proteins for activation of NOX family NADPH oxidases,” Methods in Molecular Biology (Clifton, N.J.), vol. 1982, pp. 121–137, 2019. View at: Publisher Site | Google Scholar
  153. F. Wu, H. Xiong, and S. Sha, “Noise-induced loss of sensory hair cells is mediated by ROS/AMPKα pathway,” Redox Biology, vol. 29, article 101406, 2020. View at: Publisher Site | Google Scholar
  154. H. Xiong, L. Lai, Y. Ye, and Y. Zheng, “Glucose protects cochlear hair cells against oxidative stress and attenuates noise-induced hearing loss in mice,” Neuroscience Bulletin, vol. 37, no. 5, pp. 657–668, 2021. View at: Publisher Site | Google Scholar
  155. T. Fujita, D. Yamashita, S. Katsunuma, S. Hasegawa, H. Tanimoto, and K. I. Nibu, “Increased inner ear susceptibility to noise injury in mice with streptozotocin-induced diabetes,” Diabetes, vol. 61, no. 11, pp. 2980–2986, 2012. View at: Publisher Site | Google Scholar
  156. M. Fredrich and R. Illing, “MMP-2 is involved in synaptic remodeling after cochlear lesion,” Neuroreport, vol. 21, no. 5, pp. 324–327, 2010. View at: Publisher Site | Google Scholar
  157. C. Overall and C. López-Otín, “Strategies for MMP inhibition in cancer: innovations for the post-trial era,” Nature Reviews. Cancer, vol. 2, no. 9, pp. 657–672, 2002. View at: Publisher Site | Google Scholar
  158. B. Hu, Q. Cai, Z. Hu et al., “Metalloproteinases and their associated genes contribute to the functional integrity and noise-induced damage in the cochlear sensory epithelium,” The Journal of Neuroscience: The Official Journal of the Society for Neuroscience, vol. 32, no. 43, pp. 14927–14941, 2012. View at: Publisher Site | Google Scholar
  159. J. S. Park, S. J. Kang, M. K. Seo, I. Jou, H. G. Woo, and S. M. Park, “Role of cysteinyl leukotriene signaling in a mouse model of noise-induced cochlear injury,” Proceedings of the National Academy of Sciences, vol. 111, no. 27, pp. 9911–9916, 2014. View at: Publisher Site | Google Scholar
  160. X. Wang, M. Streeter, Y. P. Liu, and H. B. Zhao, “Identification and characterization of pannexin expression in the mammalian cochlea,” The Journal of Comparative Neurology, vol. 512, no. 3, pp. 336–346, 2009. View at: Publisher Site | Google Scholar
  161. J. Abitbol, J. J. Kelly, K. Barr, A. L. Schormans, D. W. Laird, and B. L. Allman, “Differential effects of pannexins on noise-induced hearing loss,” The Biochemical Journal, vol. 473, no. 24, pp. 4665–4680, 2016. View at: Publisher Site | Google Scholar
  162. S. Wang, L. G. Yu, R. P. Liu et al., “Gene-gene interaction of GJB2, SOD2, and CAT on occupational noise-induced hearing loss in Chinese Han population,” Biomedical and Environmental Sciences: BES, vol. 27, no. 12, pp. 965–968, 2014. View at: Publisher Site | Google Scholar
  163. A. Konings, L. van Laer, M. Pawelczyk et al., “Association between variations in CAT and noise-induced hearing loss in two independent noise-exposed populations,” Human Molecular Genetics, vol. 16, no. 15, pp. 1872–1883, 2007. View at: Publisher Site | Google Scholar
  164. B. S. Wang, K. Xu, H. Zhang et al., “Association between NFE2L2 gene polymorphisms and noise-induced hearing loss in a Chinese population,” Biomedical and Environmental Sciences, vol. 32, no. 6, pp. 465–470, 2019. View at: Publisher Site | Google Scholar
  165. J. Lavinsky, A. L. Crow, C. Pan et al., “Genome-wide association study identifies nox3 as a critical gene for susceptibility to noise-induced hearing loss,” PLoS Genetics, vol. 11, no. 4, article e1005094, 2015. View at: Publisher Site | Google Scholar
  166. A. Konings, L. van Laer, S. Michel et al., “Variations in HSP70 genes associated with noise-induced hearing loss in two independent populations,” European Journal of Human Genetics, vol. 17, no. 3, pp. 329–335, 2009. View at: Publisher Site | Google Scholar
  167. C. Y. Lin, J. L. Wu, T. S. Shih, P. J. Tsai, Y. M. Sun, and Y. L. Guo, “Glutathione S-transferase M1, T1, and P1 polymorphisms as susceptibility factors for noise-induced temporary threshold shift,” Hearing Research, vol. 257, no. 1-2, pp. 8–15, 2009. View at: Publisher Site | Google Scholar
  168. H. Shen, X. Huo, K. Liu et al., “Genetic variation in GSTM1 is associated with susceptibility to noise-induced hearing loss in a Chinese population,” Journal of Occupational and Environmental Medicine, vol. 54, no. 9, pp. 1157–1162, 2012. View at: Publisher Site | Google Scholar
  169. H. Shen, J. Dou, L. Han et al., “Genetic variation in APE1 gene promoter is associated with noise-induced hearing loss in a Chinese population,” International Archives of Occupational and Environmental Health, vol. 89, no. 4, article 1100, pp. 621–628, 2016. View at: Publisher Site | Google Scholar
  170. H. Shen, J. Cao, Z. Hong et al., “A functional Ser326Cys polymorphism in hOGG1 is associated with noise-induced hearing loss in a Chinese population,” PLoS One, vol. 9, no. 3, article e89662, 2014. View at: Publisher Site | Google Scholar
  171. Y. Wu, J. Ni, M. Qi et al., “Associations of genetic variation in CASP3 gene with noise-induced hearing loss in a Chinese population: a case–control study,” Environmental Health, vol. 16, no. 1, p. 78, 2017. View at: Publisher Site | Google Scholar
  172. C. Elfgang, R. Eckert, H. Lichtenberg-Fraté et al., “Specific permeability and selective formation of gap junction channels in connexin-transfected HeLa cells,” The Journal of Cell Biology, vol. 129, no. 3, pp. 805–817, 1995. View at: Publisher Site | Google Scholar
  173. H. Zhao, N. Yu, and C. Fleming, “Gap junctional hemichannel-mediated ATP release and hearing controls in the inner ear,” Proceedings of the National Academy of Sciences of the United States of America, vol. 102, no. 51, pp. 18724–18729, 2005. View at: Publisher Site | Google Scholar
  174. E. van Eyken, L. van Laer, E. Fransen et al., “The contribution of GJB2 (Connexin 26) 35delG to age-related hearing impairment and noise-induced hearing loss,” Otology & Neurotology, vol. 28, no. 7, pp. 970–975, 2007. View at: Publisher Site | Google Scholar
  175. L. van Laer, P. I. Carlsson, N. Ottschytsch et al., “The contribution of genes involved in potassium-recycling in the inner ear to noise-induced hearing loss,” Human Mutation, vol. 27, no. 8, pp. 786–795, 2006. View at: Publisher Site | Google Scholar
  176. M. Pawelczyk, L. van Laer, E. Fransen et al., “Analysis of gene polymorphisms associated with K ion circulation in the inner ear of patients susceptible and resistant to noise-induced hearing loss,” Annals of Human Genetics, vol. 73, no. 4, pp. 411–421, 2009. View at: Publisher Site | Google Scholar
  177. X. Zhang, Y. Ni, Y. Liu et al., “Screening of noise-induced hearing loss (NIHL)-associated SNPs and the assessment of its genetic susceptibility,” Environmental Health, vol. 18, no. 1, p. 30, 2019. View at: Publisher Site | Google Scholar
  178. B. M. Johnstone, R. Patuzzi, J. Syka, and E. Syková, “Stimulus-related potassium changes in the organ of Corti of guinea-pig,” The Journal of Physiology, vol. 408, no. 1, pp. 77–92, 1989. View at: Publisher Site | Google Scholar
  179. A. Konings, L. van Laer, A. Wiktorek-Smagur et al., “Candidate gene association study for noise-induced hearing loss in two independent noise-exposed populations,” Annals of Human Genetics, vol. 73, no. 2, pp. 215–224, 2009. View at: Publisher Site | Google Scholar
  180. T. J. Kowalski, M. Pawelczyk, E. Rajkowska, A. Dudarewicz, and M. Sliwinska-Kowalska, “Genetic variants of CDH23 associated with noise-induced hearing loss,” Otology & Neurotology, vol. 35, no. 2, pp. 358–365, 2014. View at: Publisher Site | Google Scholar
  181. A. Brake, M. Wagenbach, and D. Julius, “New structural motif for ligand-gated ion channels defined by an ionotropic ATP receptor,” Nature, vol. 371, no. 6497, pp. 519–523, 1994. View at: Publisher Site | Google Scholar
  182. F. Mazzarda, A. Delia, R. Massari et al., “Organ-on-chip model shows that ATP release through connexin hemichannels drives spontaneous Ca2+signaling in non-sensory cells of the greater epithelial ridge in the developing cochlea,” Lab on a Chip, vol. 20, no. 16, pp. 3011–3023, 2020. View at: Publisher Site | Google Scholar
  183. D. Yan, Y. Zhu, T. Walsh et al., “Mutation of the ATP-gated P2X(2) receptor leads to progressive hearing loss and increased susceptibility to noise,” Proceedings of the National Academy of Sciences, vol. 110, no. 6, pp. 2228–2233, 2013. View at: Publisher Site | Google Scholar
  184. Y. Niu, C. Xie, Z. Du et al., “Genome-wide association study identifies 7q11.22 and 7q36.3 associated with noise-induced hearing loss among Chinese population,” Journal of Cellular and Molecular Medicine, vol. 25, no. 1, pp. 411–420, 2021. View at: Publisher Site | Google Scholar
  185. K. Hori, T. Nagai, W. Shan et al., “Cytoskeletal regulation by AUTS2 in neuronal migration and neuritogenesis,” Cell Reports, vol. 9, no. 6, pp. 2166–2179, 2014. View at: Publisher Site | Google Scholar
  186. E. Ding, J. Liu, H. Guo et al., “DNMT1 and DNMT3A haplotypes associated with noise-induced hearing loss in Chinese workers,” Scientific Reports, vol. 8, no. 1, article 12193, 2018. View at: Publisher Site | Google Scholar
  187. X. Zhang, Y. Liu, L. Zhang et al., “Associations of genetic variations in EYA4, GRHL2 and DFNA5 with noise-induced hearing loss in Chinese population: a case-control study,” Environmental Health, vol. 14, no. 1, p. 77, 2015. View at: Publisher Site | Google Scholar
  188. H. Guo, E. Ding, Y. Bai et al., “Association of genetic variations in FOXO3 gene with susceptibility to noise induced hearing loss in a Chinese population,” PLoS One, vol. 12, no. 12, article e0189186, 2017. View at: Publisher Site | Google Scholar
  189. X. Li, X. Huo, K. Liu et al., “Association between genetic variations in GRHL2 and noise-induced hearing loss in Chinese high intensity noise exposed workers: a case-control analysis,” Industrial Health, vol. 51, no. 6, pp. 612–621, 2013. View at: Publisher Site | Google Scholar
  190. X. Xu, Q. Yang, J. Jiao et al., “Genetic variation in POU4F3 and GRHL2 associated with noise-induced hearing loss in Chinese population: a case-control study,” International Journal of Environmental Research and Public Health, vol. 13, no. 6, p. 561, 2016. View at: Publisher Site | Google Scholar
  191. B. Wang, E. Ding, H. Shen et al., “Association of TagSNP in lncRNA HOTAIR with susceptibility to noise-induced hearing loss in a Chinese population,” Hearing Research, vol. 347, pp. 41–46, 2017. View at: Publisher Site | Google Scholar
  192. E. Ding, J. Liu, H. Shen et al., “Notch polymorphisms associated with sensitivity of noise induced hearing loss among Chinese textile factory workers,” BMC Medical Genetics, vol. 19, no. 1, p. 168, 2018. View at: Publisher Site | Google Scholar
  193. Y. Grondin, M. E. Bortoni, R. Sepulveda et al., “Genetic polymorphisms associated with hearing threshold shift in subjects during first encounter with occupational impulse noise,” PLoS One, vol. 10, no. 6, article e0130827, 2015. View at: Publisher Site | Google Scholar
  194. M. A. Han, “Therapeutic effect of dexamethasone for noise-induced hearing loss: systemic versus intratympanic injection in mice,” Otology & Neurotology, vol. 36, no. 5, pp. 755–762, 2015. View at: Publisher Site | Google Scholar
  195. J. Kil, E. Lobarinas, C. Spankovich et al., “Safety and efficacy of ebselen for the prevention of noise-induced hearing loss: a randomised, double-blind, placebo-controlled, phase 2 trial,” Lancet (London, England), vol. 390, no. 10098, pp. 969–979, 2017. View at: Publisher Site | Google Scholar
  196. A. Fetoni, P. de Bartolo, S. L. M. Eramo et al., “Noise-induced hearing loss (NIHL) as a target of oxidative stress-mediated damage: cochlear and cortical responses after an increase in antioxidant defense,” The Journal of Neuroscience: The Official Journal of the Society for Neuroscience, vol. 33, no. 9, pp. 4011–4023, 2013. View at: Publisher Site | Google Scholar
  197. G. Lenaz, R. Fato, G. Formiggini, and M. L. Genova, “The role of coenzyme Q in mitochondrial electron transport,” Mitochondrion, vol. 7, pp. S8–S33, 2007. View at: Publisher Site | Google Scholar
  198. M. Oz, D. E. Lorke, M. Hasan, and G. A. Petroianu, “Cellular and molecular actions of methylene blue in the nervous system,” Medicinal Research Reviews, vol. 31, no. 1, pp. 93–117, 2011. View at: Publisher Site | Google Scholar
  199. J. Park, I. Jou, and S. Park, “Attenuation of noise-induced hearing loss using methylene blue,” Cell Death & Disease, vol. 5, no. 4, article e1200, 2014. View at: Publisher Site | Google Scholar
  200. A. Umugire, S. Lee, D. Kim, M. Choi, H. S. Kim, and H. H. Cho, “Avenanthramide-C prevents noise- and drug-induced hearing loss while protecting auditory hair cells from oxidative stress,” Cell Death Discovery, vol. 5, no. 1, p. 115, 2019. View at: Publisher Site | Google Scholar
  201. M. Huang, A. Kantardzhieva, D. Scheffer, M. C. Liberman, and Z. Y. Chen, “Hair cell overexpression of Islet1 reduces age-related and noise-induced hearing loss,” The Journal of Neuroscience: The Official Journal of the Society for Neuroscience, vol. 33, no. 38, pp. 15086–15094, 2013. View at: Publisher Site | Google Scholar
  202. R. Horie, T. Sakamoto, T. Nakagawa, T. Ishihara, M. Higaki, and J. Ito, “Stealth-nanoparticle strategy for enhancing the efficacy of steroids in mice with noise-induced hearing loss,” Nanomedicine (London, England), vol. 5, no. 9, pp. 1331–1340, 2010. View at: Publisher Site | Google Scholar
  203. X. Xu, K. Lin, Y. Wang et al., “A metal-organic framework based inner ear delivery system for the treatment of noise-induced hearing loss,” Nanoscale, vol. 12, no. 30, pp. 16359–16365, 2020. View at: Publisher Site | Google Scholar
  204. L. Liu, Y. Chen, J. Qi et al., “Wnt activation protects against neomycin-induced hair cell damage in the mouse cochlea,” Cell Death & Disease, vol. 7, no. 3, article e2136, 2016. View at: Publisher Site | Google Scholar
  205. Y. Zhang, S. Zhang, Z. Zhang et al., “Knockdown of Foxg1 in Sox9+ supporting cells increases the trans-differentiation of supporting cells into hair cells in the neonatal mouse utricle,” Aging (Albany NY), vol. 12, no. 20, article 104009, pp. 19834–19851, 2020. View at: Publisher Site | Google Scholar
  206. R. Guo, S. Zhang, M. Xiao et al., “Accelerating bioelectric functional development of neural stem cells by graphene coupling: implications for neural interfacing with conductive materials,” Biomaterials, vol. 106, pp. 193–204, 2016. View at: Publisher Site | Google Scholar
  207. R. Guo, M. Xiao, W. Zhao et al., “2D Ti3C2TxMXene couples electrical stimulation to promote proliferation and neural differentiation of neural stem cells,” Acta Biomaterialia, vol. S1742-7061, no. 20, pp. 30749–30752, 2020. View at: Publisher Site | Google Scholar
  208. R. Guo, J. Li, C. Chen et al., “Biomimetic 3D bacterial cellulose-graphene foam hybrid scaffold regulates neural stem cell proliferation and differentiation,” Colloids and Surfaces. B, Biointerfaces, vol. 200, article 111590, 2021. View at: Publisher Site | Google Scholar

Copyright © 2021 Huanyu Mao and Yan Chen. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.


More related articles

 PDF Download Citation Citation
 Download other formatsMore
 Order printed copiesOrder
Views627
Downloads252
Citations

Related articles

Article of the Year Award: Outstanding research contributions of 2020, as selected by our Chief Editors. Read the winning articles.